ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Venture Capitalists Raised Investment In 2011

by Marc S. Reisch
January 30, 2012 | APPEARED IN VOLUME 90, ISSUE 5

In 2011, venture capital investors poured $28.4 billion into start-up firms, up 22% from the year earlier. However, more money went to existing portfolio companies and less into early-stage start-ups, according to the MoneyTree investment report by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters. Venture capitalists put $4.7 billion into biotechnology start-ups, the report found, up 22% from the year before. However, they completed only 446 deals, 9% fewer than the year before. The story was a little different for the clean technology sector. Investors put $4.3 billion into 323 cleantech deals for a 12% increase in both dollars and number of deals. In the biotech and cleantech sectors, continued investment in existing portfolio firms is “driven by the challenging exit market, which requires venture capitalists to fuel their existing portfolios longer and at greater investment levels than in the past,” says NVCA President Mark G. Heesen.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment